BeiGene Statistics

Total Valuation

BeiGene has a market cap or net worth of HKD 229.95 billion. The enterprise value is 217.91 billion.

Market Cap	229.95B
Enterprise Value	217.91B

Important Dates

The next estimated earnings date is Wednesday, May 14, 2025.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.86%
Shares Change (QoQ)	+1.23%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	74.33M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	9.02
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-43.51
EV / Sales	7.35
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-44.30

Financial Position

The company has a current ratio of 1.80, with a Debt / Equity ratio of 0.32.

Current Ratio	1.80
Quick Ratio	1.51
Debt / Equity	0.32
Debt / EBITDA	n/a
Debt / FCF	-1.71
Interest Coverage	-38.61

Financial Efficiency

Return on equity (ROE) is -18.77% and return on invested capital (ROIC) is -8.01%.

Return on Equity (ROE)	-18.77%
Return on Assets (ROA)	-6.07%
Return on Invested Capital (ROIC)	-8.01%
Return on Capital Employed (ROCE)	-15.35%
Revenue Per Employee	2.69M
Profits Per Employee	-455,307
Employee Count	11,000
Asset Turnover	0.65
Inventory Turnover	1.30

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +73.58% in the last 52 weeks. The beta is 0.65, so BeiGene's price volatility has been lower than the market average.

Beta (5Y)	0.65
52-Week Price Change	+73.58%
50-Day Moving Average	148.73
200-Day Moving Average	122.20
Relative Strength Index (RSI)	58.20
Average Volume (20 Days)	5,158,358

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.52

Income Statement

In the last 12 months, BeiGene had revenue of HKD 29.60 billion and -5.01 billion in losses. Loss per share was -47.57.

Revenue	29.60B
Gross Profit	24.98B
Operating Income	-4.42B
Pretax Income	-4.14B
Net Income	-5.01B
EBITDA	-3.12B
EBIT	-4.42B
Loss Per Share	-47.57

Full Income Statement

Balance Sheet

The company has 20.41 billion in cash and 8.39 billion in debt, giving a net cash position of 12.02 billion.

Cash & Cash Equivalents	20.41B
Total Debt	8.39B
Net Cash	12.02B
Net Cash Per Share	n/a
Equity (Book Value)	25.88B
Book Value Per Share	242.53
Working Capital	13.80B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.09 billion and capital expenditures -3.83 billion, giving a free cash flow of -4.92 billion.

Operating Cash Flow	-1.09B
Capital Expenditures	-3.83B
Free Cash Flow	-4.92B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 84.41%, with operating and profit margins of -14.93% and -16.92%.

Gross Margin	84.41%
Operating Margin	-14.93%
Pretax Margin	-13.99%
Profit Margin	-16.92%
EBITDA Margin	-10.55%
EBIT Margin	-14.93%
FCF Margin	n/a

Dividends & Yields

BeiGene does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.86%
Shareholder Yield	-0.86%
Earnings Yield	-2.18%
FCF Yield	-2.14%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BeiGene has an Altman Z-Score of 2.93. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.93
Piotroski F-Score	n/a